Whitehawk Therapeutics Inc
NASDAQ:WHWKBiotechnology
+$0.06 today
- Market cap
- $184.70M
- Beta
- 0.77
- P/E (TTM)
- -2.6
- EPS (TTM)
- -$1.67
Volume 0.28M
Average 0.31M
WHWK Accumulated OCI
Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.
Whitehawk Therapeutics IncNASDAQ: WHWK
Accumulated OCI · Q1 FY2026 · quarter ended Mar 2026
Accumulated OCI turns negative
Q1 FY2026 Accumulated OCI was -$15K, compared with $1K a year earlier.
Context
- Accumulated OCI amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Accumulated OCI increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether Accumulated OCI keeps falling in the next quarterly balance sheet after a -1600.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Accumulated OCI history
USD · from the balance sheet
- Latest · FY2025
- 120K USD
- Year-over-year change
- +650.0%
| Period | Period end | Accumulated OCI | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 120K | +650.0% |
| FY2024 | 2024-12-31 | 16K | -40.7% |
| FY2023 | 2023-12-31 | 27K | +123.5% |
| FY2022 | 2022-12-31 | (115K) | — |
| FY2021 | 2021-12-31 | 0 | — |
Accumulated OCI vs competitors
How WHWK compares with its peers on the latest reported figures
- Peers report in different currencies, so Accumulated OCI is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -1600.0% is the 7th highest of 8, against a peer median of -114.0%.
- Accumulated OCI amounts to 0.0% of total assets for WHWK, versus a peer median of 0.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | CA$6.23M CAD | +549.8% | +134.5% | 76.3% | |
| Mar 2026 | $216K USD | +151.2% | -5.4% | 1.0% | |
| Mar 2026 | $105.64K USD | +583.2% | -11.6% | 0.1% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
WHWKWhitehawk Therapeutics Inc | Mar 2026 | -$15K USD | -1600.0% | — | 0.0% |
| Mar 2026 | -$27K USD | -2600.0% | — | 0.0% | |
| Mar 2026 | -$50K USD | -114.0% | — | 0.0% | |
| Mar 2026 | -$341K USD | -314.5% | — | 0.2% | |
| Mar 2026 | -$422K USD | -779.2% | — | 0.2% | |
| Peer median (excluding WHWK) | — | -114.0% | -5.4% | 0.1% | |
Competitors are the stored peer set for WHWK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 148.99M | 39.02M | 62.89M | 28.67M | 37.57M |
| Short-term Investments | 0 | 133.54M | 45.96M | 18.57M | 108.13M |
| Net Receivables | 0 | 1.86M | 5.49M | 5.9M | 0 |
| Inventory | 0 | 1.86M | 6.43M | 5.31M | 0 |
| Other Current Assets | 0 | 0 | 3.83M | 0 | 3.32M |
| Total Current Assets | 151.27M | 180.03M | 124.59M | 61.29M | 149.01M |
| Property, Plant & Equipment (Net) | 614K | 2.03M | 5.97M | 7.63M | 3K |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 3.81M | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 2.21M | 2.18M | 1.87M | 1.4M | 1.81M |
| Total Non-current Assets | 6.64M | 4.21M | 7.84M | 9.03M | 1.82M |
| Total Assets | 157.91M | 184.24M | 132.42M | 70.32M | 150.83M |
| Account Payables | 6.44M | 3.52M | 5.9M | 2.16M | 917K |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.47M | 1.57M | 3.08M | 64K | 3.16M |
| Total Current Liabilities | 15.27M | 18.84M | 26.4M | 17.07M | 14.52M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 5.76M | 5.76M | 0 | 202K | 0 |
| Total Non-current Liabilities | 6.23M | 7.02M | 833K | 767K | 0 |
| Total Liabilities | 21.5M | 25.86M | 27.23M | 17.84M | 14.52M |
| Common Stock | 2K | 2K | 2K | 2K | 4K |
| Retained Earnings | (142.69M) | (203.2M) | (268.96M) | (332.65M) | (353.25M) |
| Accumulated OCI | 0 | (115K) | 27K | 16K | 120K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 136.41M | 158.38M | 105.2M | 52.48M | 136.31M |
| Total Debt | 605K | 1.66M | 1.27M | 833K | 0 |
| Net Debt | (148.38M) | (37.36M) | (61.62M) | (27.84M) | (37.57M) |
Whitehawk Therapeutics Inc
NASDAQ:WHWK
Intrinsic Alpha fair value
Locked
Current Price
$3.13
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.